What does CUSIP 44052TAB7 represent in this 13F holders report?

CUSIP 44052TAB7 is the security identifier for 44052TAB7 - HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 used to aggregate holder disclosures.

How many institutions held 44052TAB7 - HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 in Q3 2020?

No institutional holders were reported for 44052TAB7 - HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 in Q3 2020; review adjacent reporting periods for trend context.

HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1

CUSIP: 44052TAB7

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class: Debt / NOTE 2.500% 3/1
Total 13F principal: $0
Principal change: -$181,474,500
Total reported market value: $0
Number of holders: 0
Value change: -$352,716,000
Number of sells: 20

Quarterly Holders Quick Answers

What is CUSIP 44052TAB7?
CUSIP 44052TAB7 identifies 44052TAB7 - HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q2 2020

Recent filing periods for CUSIP 44052TAB7:

Q3 2020 Q2 2020 Q1 2020 Q4 2019 Q3 2019 Q2 2019 Q1 2019 Q4 2018

HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1

Q3 2020 13F Holders as of 30 Sep 2020

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 as of Q3 2020.